|

Enoblituzumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MGA271

Pipeline

Phase 2: 1

Top Sponsors

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Indications

  • Prostate Cancer1
  • Cancer1

Chicago, Illinois1 trial

Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer

Northewestern University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.